Bill renews federal opioid and mental health programs through 2026-2030

What does this do?

This law reauthorizes a major federal program addressing opioid addiction, mental health, and substance use, originally created by the 2018 SUPPORT Act. It mostly extends funding for existing programs through 2026-2030, often at increased dollar amounts, while adding smaller policy changes like a new fentanyl work group and updated guidance on drug disposal and overdose reversal drugs.

Who does it affect?

The bill affects pregnant women and new mothers dealing with substance use, children exposed to trauma or prenatal alcohol, addiction treatment providers, first responders, and people in recovery. It also affects state and tribal governments, pharmacies, prescribers, and users of the 988 crisis line.

Why does it matter?

Existing federal anti-opioid and mental health infrastructure will continue operating under updated funding levels rather than a new approach, meaning current program structures and rules remain largely intact.

What does it cost, and who pays?

• Funding extended through 2026-2030
• Dollar amounts often increased
• Exact figures not specified